Fish and no chips
Smarter than the average zebra TO PIN one big evolutionary shift on a particular molecule is ambitious. To pin two on it is truly audacious. Yet doing so was just one of the ideas floating around at “A Celebration of DHA” in London this week. The celebration in question was a scientific meeting, rather than a festival. It was definitely, however, a love-in. It was held on May 26th and 27th at the
Making a bit of me
OpinionLeadersLetters to the editorBy InvitationCurrent topicsIsrael and HamasWar in UkraineUS elections 2024The World Ahead 2024Climate changeCoronavirusThe world economyThe Economist explainsArtificial intelligenceCurrent topicsIsrael and HamasWar in UkraineUS elections 2024The World Ahead 2024Climate changeCoronavirusThe world economyThe Economist explainsArtificial intelligenceWorldThe world t
Potential encapsulated
OpinionLeadersLetters to the editorBy InvitationCurrent topicsIsrael and HamasWar in UkraineUS elections 2024The World Ahead 2024Climate changeCoronavirusThe world economyThe Economist explainsArtificial intelligenceCurrent topicsIsrael and HamasWar in UkraineUS elections 2024The World Ahead 2024Climate changeCoronavirusThe world economyThe Economist explainsArtificial intelligenceWorldThe world t
Mix and match
OpinionLeadersLetters to the editorBy InvitationCurrent topicsIsrael and HamasWar in UkraineUS elections 2024The World Ahead 2024Climate changeCoronavirusThe world economyThe Economist explainsArtificial intelligenceCurrent topicsIsrael and HamasWar in UkraineUS elections 2024The World Ahead 2024Climate changeCoronavirusThe world economyThe Economist explainsArtificial intelligenceWorldThe world t
A spoonful of ingenuity
A spoonful of ingenuityNew ideas for raising money for medical care—and spending it Reuters IN THE old days, the job of eradicating disease fell to governments and inter-governmental bodies. Then charities, often led by celebrities or entrepreneurs, joined in. Finally, in the Western world at least, governments accepted the need to pool their efforts with those of private donors, big and small. Th
Dashed hopes
OpinionLeadersLetters to the editorBy InvitationCurrent topicsIsrael and HamasWar in UkraineUS elections 2024The World Ahead 2024Climate changeCoronavirusThe world economyThe Economist explainsArtificial intelligenceCurrent topicsIsrael and HamasWar in UkraineUS elections 2024The World Ahead 2024Climate changeCoronavirusThe world economyThe Economist explainsArtificial intelligenceWorldThe world t
Arousing interest
Arousing interestThe search continues for a pill that will lift a woman’s libido BACK in the 1990s a drug firm called Pfizer thought it had a treatment for angina. Unfortunately, the new medicine failed its clinical trials. But a curious side-effect was seen in those trials—and Viagra was born. It has helped make Pfizer into a pharmaceutical powerhouse and, since then, people have wondered if what
リリース、障害情報などのサービスのお知らせ
最新の人気エントリーの配信
j次のブックマーク
k前のブックマーク
lあとで読む
eコメント一覧を開く
oページを開く
A nasty rash
Pass the bill
Agony column
A game of consequences?
Clear diagnosis, uncertain remedy
That way, madness lies
Drug money
Seconds out
In the eye
Son et lumière meets surgery
Back to the lab
After the gold rush
Say “aaaarrrghhhh”!